英文原著
1. Fujiwara M, Kimura H, Tanaka T, Saito H, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Association between malnutrition and adverse renal outcomes in patients with type 2 diabetes. J Diabetes Investig 2025;16:100-107. pubmed
5. Ma E, et al. Obesity indices in identifying type 2 diabetes mellitus: a longitudinal study of the Fukushima Health Database 2015-2021. Diabetol Metab Syndr pubmed
6. Sakai A, et al. Changes in peripheral blood test results among adults in the six years following the Great East Japan Earthquake: the Fukushima Health Management Survey. Fukushima J Med Sci in press
8. Teragawa H, et al. Impact of baseline left ventricular ejection fraction and body mass index on the effect of 24-week Ipragliflozin treatment on left ventricular diastolic function in patients with type 2 diabetes and chronic kidney disease: insights from the PROCEED trial. Cardiovasc Diabetol 2025;24:190. pubmed
9. Watanabe G, Horita S, et al. Canagliflozin-Induced Renal Glutathione Distribution Mapping in non-Diabetic Male Rat Kidneys. Physiol Rep pubmed
2. Holmes-Truscott E, et al. Experiences of diabetes stigma among adults with type 1 and type 2 diabetes: a multi-study, multi-country, secondary analysis. Diabet Med pubmed
3. Kimura H, et al. Association of red blood cell distribution width/albumin ratio with renal prognosis among patients with type 2 diabetes mellitus: a retrospective cohort study. J Diabetes Investig in press pubmed
4. Kobashi Y, et al. Longitudinal health checkup access pattern following a triple disaster using latent class growth analysis: The Fukushima Health Management Survey. Public Health pubmed
3. Kimura H, et al. Association of red blood cell distribution width/albumin ratio with renal prognosis among patients with type 2 diabetes mellitus: a retrospective cohort study. J Diabetes Investig in press pubmed
4. Kobashi Y, et al. Longitudinal health checkup access pattern following a triple disaster using latent class growth analysis: The Fukushima Health Management Survey. Public Health pubmed
5. Ma E, et al. Obesity indices in identifying type 2 diabetes mellitus: a longitudinal study of the Fukushima Health Database 2015-2021. Diabetol Metab Syndr pubmed
6. Sakai A, et al. Changes in peripheral blood test results among adults in the six years following the Great East Japan Earthquake: the Fukushima Health Management Survey. Fukushima J Med Sci in press
7. Tanaka K, et al. The relationship of the ratio of platelet distribution width to serum albumin with kidney disease progression in patients with hypertension. Sci Rep in press
8. Teragawa H, et al. Impact of baseline left ventricular ejection fraction and body mass index on the effect of 24-week Ipragliflozin treatment on left ventricular diastolic function in patients with type 2 diabetes and chronic kidney disease: insights from the PROCEED trial. Cardiovasc Diabetol 2025;24:190. pubmed
9. Watanabe G, Horita S, et al. Canagliflozin-Induced Renal Glutathione Distribution Mapping in non-Diabetic Male Rat Kidneys. Physiol Rep pubmed
英文総説
英文症例
和文著書
斎藤悠、島袋充生 糖尿病ケトアシドーシス 糖尿病最新の治療 2025-2027 65-68頁 南江堂島袋充生、田辺隼人 機械学習に基づく日本人2型糖尿病のサブクラス分類 門脇孝、山内敏正 編 糖尿病学 2025 4-11頁 診断と治療社
和文総説
島袋充生 糖尿病クラスター分類 特集 知ってるつもり？ 知らなきゃいけない？ 新語・新概念辞典 総合診療 2025年 35巻 2号 152-153頁 医学書院島袋充生 糖尿病と心不全の最前線 特集 知っておきたい糖尿病診療の最前線 臨床雑誌内科 総合診療 2025年 135巻 3号 400-404頁 南江堂
